DD211350A5 - Neues verfahren zur herstellung von 5,11-dihydro-11-/(4-methyl-1-piperazinyl)-acetyl/-6h-pyrido/2,3-b//1,4/benzodiazepin-6-on - Google Patents
Neues verfahren zur herstellung von 5,11-dihydro-11-/(4-methyl-1-piperazinyl)-acetyl/-6h-pyrido/2,3-b//1,4/benzodiazepin-6-on Download PDFInfo
- Publication number
- DD211350A5 DD211350A5 DD83255117A DD25511783A DD211350A5 DD 211350 A5 DD211350 A5 DD 211350A5 DD 83255117 A DD83255117 A DD 83255117A DD 25511783 A DD25511783 A DD 25511783A DD 211350 A5 DD211350 A5 DD 211350A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- methyl
- dihydro
- pyrido
- piperazinyl
- benzodiazepin
- Prior art date
Links
- -1 (4-METHYL-1-PIPERAZINYL) -ACETYL Chemical class 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims abstract description 15
- YZPAKBGVJIVPEU-UHFFFAOYSA-N 1,2-benzodiazepin-6-one Chemical compound N1=NC=CC=C2C(=O)C=CC=C21 YZPAKBGVJIVPEU-UHFFFAOYSA-N 0.000 title claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 20
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 15
- 229910052744 lithium Inorganic materials 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 10
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 3
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 235000005985 organic acids Nutrition 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 239000006184 cosolvent Substances 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 claims description 2
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 150000002168 ethanoic acid esters Chemical class 0.000 claims 1
- 125000004344 phenylpropyl group Chemical group 0.000 claims 1
- RMHMFHUVIITRHF-UHFFFAOYSA-N pirenzepine Chemical compound C1CN(C)CCN1CC(=O)N1C2=NC=CC=C2NC(=O)C2=CC=CC=C21 RMHMFHUVIITRHF-UHFFFAOYSA-N 0.000 abstract description 14
- 229960004633 pirenzepine Drugs 0.000 abstract description 10
- 229910003002 lithium salt Inorganic materials 0.000 abstract description 4
- JCXZKUZXVQKENT-UHFFFAOYSA-N 2-(4-methylpiperazin-1-ium-1-yl)acetate Chemical compound CN1CCN(CC(O)=O)CC1 JCXZKUZXVQKENT-UHFFFAOYSA-N 0.000 abstract description 3
- 230000000767 anti-ulcer Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- QLLHLIFJMKQDPI-UHFFFAOYSA-N 1,2-dihydropyridin-6-ol Chemical compound OC1=CC=CCN1 QLLHLIFJMKQDPI-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 6
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 150000003222 pyridines Chemical class 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- KSSXNHGPIDAUAS-UHFFFAOYSA-N 1,4-benzodiazepin-6-one Chemical compound N1=CC=NC=C2C(=O)C=CC=C21 KSSXNHGPIDAUAS-UHFFFAOYSA-N 0.000 description 2
- MIRBIZDDMSFTKY-UHFFFAOYSA-N 5,11-dihydropyrido[2,3-b][1,4]benzodiazepin-6-one Chemical compound O=C1NC2=CC=CN=C2NC2=CC=CC=C12 MIRBIZDDMSFTKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- QETJQVJIERQYIQ-UHFFFAOYSA-N ethyl 2-(4-methylpiperazin-1-yl)acetate Chemical compound CCOC(=O)CN1CCN(C)CC1 QETJQVJIERQYIQ-UHFFFAOYSA-N 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 159000000002 lithium salts Chemical class 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- 101000588924 Anthopleura elegantissima Delta-actitoxin-Ael1a Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 description 1
- SQJBXGFHLHCFKR-UHFFFAOYSA-N benzyl 2-(4-methylpiperazin-1-yl)acetate Chemical compound C1CN(C)CCN1CC(=O)OCC1=CC=CC=C1 SQJBXGFHLHCFKR-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- QSOFJTPEADTCHW-UHFFFAOYSA-N hexyl 2-(4-methylpiperazin-1-yl)acetate Chemical compound CCCCCCOC(=O)CN1CCN(C)CC1 QSOFJTPEADTCHW-UHFFFAOYSA-N 0.000 description 1
- 238000006138 lithiation reaction Methods 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- DBYQHFPBWKKZAT-UHFFFAOYSA-N lithium;benzene Chemical compound [Li+].C1=CC=[C-]C=C1 DBYQHFPBWKKZAT-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823235795 DE3235795A1 (de) | 1982-09-28 | 1982-09-28 | Neues verfahren zur herstellung von 5,11-dihydro-11-((4-methyl-1-piperazinyl)- acetyl)- 6h-pyrido(2,3-b)(1,4)- benzodiazepin-6-on |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD211350A5 true DD211350A5 (de) | 1984-07-11 |
Family
ID=6174310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD83255117A DD211350A5 (de) | 1982-09-28 | 1983-09-26 | Neues verfahren zur herstellung von 5,11-dihydro-11-/(4-methyl-1-piperazinyl)-acetyl/-6h-pyrido/2,3-b//1,4/benzodiazepin-6-on |
Country Status (16)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3735895A1 (de) * | 1987-10-23 | 1989-05-03 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| IT1225729B (it) * | 1988-08-12 | 1990-11-26 | Menarini S A S Firenze A | Derivati della 5,5-diossido-6,11-diidrodibenzo (c,f)(1,2,5) tiadiazepina, loro sali e relativi procedimenti di fabbricazione |
| US7123562B2 (en) | 2002-06-20 | 2006-10-17 | Koninklijke Philips Electronics N. V. | Method and device for determining a set of recording pulse series parameters for optical carrier recording and optical record carrier |
| CN103044419A (zh) * | 2012-09-04 | 2013-04-17 | 苏州弘森药业有限公司 | 一种合成盐酸哌仑西平的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1130973B (it) * | 1980-03-17 | 1986-06-18 | Microsules Argentina Sa De S C | Processo per la preparazione di derivati di 5,11-di-idro-6h-pirido(2,3-b) (1,4)-benzodiazepin-6-one,derivati finali ed intermedi di sintesi in tal modo ottenuti |
-
1982
- 1982-09-28 DE DE19823235795 patent/DE3235795A1/de not_active Withdrawn
-
1983
- 1983-09-17 DE DE8383109230T patent/DE3369847D1/de not_active Expired
- 1983-09-17 EP EP83109230A patent/EP0104566B1/de not_active Expired
- 1983-09-17 AT AT83109230T patent/ATE25524T1/de not_active IP Right Cessation
- 1983-09-20 FI FI833349A patent/FI73680C/fi not_active IP Right Cessation
- 1983-09-24 KR KR1019830004476A patent/KR840006244A/ko not_active Withdrawn
- 1983-09-26 DD DD83255117A patent/DD211350A5/de unknown
- 1983-09-26 GR GR72533A patent/GR79679B/el unknown
- 1983-09-27 ES ES525969A patent/ES525969A0/es active Granted
- 1983-09-27 CS CS837048A patent/CS236894B2/cs unknown
- 1983-09-27 CA CA000437625A patent/CA1202625A/en not_active Expired
- 1983-09-27 PL PL1983243918A patent/PL139939B1/pl unknown
- 1983-09-27 NO NO833474A patent/NO833474L/no unknown
- 1983-09-27 HU HU833352A patent/HU187976B/hu unknown
- 1983-09-27 DK DK441183A patent/DK441183A/da not_active Application Discontinuation
- 1983-09-27 PT PT77401A patent/PT77401B/pt unknown
- 1983-09-27 JP JP58179100A patent/JPS5980684A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CS236894B2 (en) | 1985-05-15 |
| EP0104566B1 (de) | 1987-02-25 |
| ES8405793A1 (es) | 1984-06-16 |
| PL243918A1 (en) | 1984-09-10 |
| GR79679B (enrdf_load_stackoverflow) | 1984-10-31 |
| FI73680B (fi) | 1987-07-31 |
| PT77401A (de) | 1983-10-01 |
| FI833349L (fi) | 1984-03-29 |
| FI833349A0 (fi) | 1983-09-20 |
| CA1202625A (en) | 1986-04-01 |
| PL139939B1 (en) | 1987-03-31 |
| NO833474L (no) | 1984-03-29 |
| PT77401B (de) | 1986-03-20 |
| EP0104566A2 (de) | 1984-04-04 |
| EP0104566A3 (en) | 1985-05-15 |
| ATE25524T1 (de) | 1987-03-15 |
| KR840006244A (ko) | 1984-11-22 |
| FI73680C (fi) | 1987-11-09 |
| DK441183D0 (da) | 1983-09-27 |
| ES525969A0 (es) | 1984-06-16 |
| DE3369847D1 (en) | 1987-04-02 |
| DE3235795A1 (de) | 1984-03-29 |
| DK441183A (da) | 1984-03-29 |
| JPS5980684A (ja) | 1984-05-10 |
| HU187976B (en) | 1986-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0893426B1 (de) | 2-Phasen-Herstellung von Carbonsäureestern | |
| CH624920A5 (en) | Process for the preparation of trans-2,2-dimethyl-3-(2,2-dichloroethenyl)cyclopropane-1-carboxylic acid and its esters | |
| EP0104566B1 (de) | Verfahren zur Herstellung von 5,11-Dihydro-11-((4-methyl-1-piperazinyl)-acetyl)-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-on | |
| DE60109829T2 (de) | 3-(1-Hydroxy-pentylidene)-5-nitro-3H-benzofuran-2-on, ein Verfahren zu seiner Herstellung und seine Verwendung | |
| DE1620286B1 (de) | Verfahren zur Herstellung von Pyrrolderivaten | |
| EP0336250B1 (de) | Verfahren zur Herstellung von 5-gliedrigen, stickstoffhaltigen Heteroaromaten | |
| DE1237567B (de) | Verfahren zur Herstellung von delta 5-6-Methylsteroiden | |
| CH653996A5 (de) | Tryptaminderivate und verfahren zu deren herstellung. | |
| DE3871591T2 (de) | Verfahren zur herstellung von 1-propargyl-2,4-dioxoimidazolidin. | |
| EP0102318B1 (de) | Herstellung von beta-Amino-alpha,beta-ungesättigten Carbonsäureestern | |
| DD148779A5 (de) | Verfahren zur herstellung von vindesin | |
| EP0302227B1 (de) | 5-Halogen-6-amino-nikotin-säurehalogenide, ihre Herstellung und ihre Verwendung | |
| EP0299277A2 (de) | Verfahren zur Herstellung von substituierten Pyridylalkylketonen | |
| DE3639583C2 (enrdf_load_stackoverflow) | ||
| DE4408083C1 (de) | Verfahren zur Herstellung von 4-Fluoralkoxyzimtsäurenitrilen | |
| DE2065698A1 (de) | Verfahren zur herstellung von 2isopropyl-6-methyl-4(3h)-pyrimidon | |
| EP0552759A1 (de) | Verfahren zur Herstellung von 4,6-Dialkoxypyrimidinen | |
| DE1815788A1 (de) | 4,5-substituierte N-Oxy- und Hydroxyhydoimidazole | |
| DE2830060C2 (de) | Schwefelsäurehalbester des 4-Hydroxybenzylcyamids und Verfahren zu deren Herstellung | |
| DD143256A5 (de) | Verfahren zur herstellung von n-cyano-n'-methyl-n"-(2-eckige klammer auf (4-methyl-5-imidazolyl)-methylthio eckige klammer zu -aethyl)-guanidin | |
| DE3429667C2 (enrdf_load_stackoverflow) | ||
| DE2819462C2 (enrdf_load_stackoverflow) | ||
| AT333981B (de) | Verfahren zur herstellung des neuen n-(d-6-methyl-8-isoergolin-i-yl)-n',n'-diathylharnstoffs | |
| DE2944953C2 (de) | Verfahren zur Herstellung von N,N'-1,1-Dimethyltrimethylen-bis-benzamid | |
| DE69908922T2 (de) | Methylbiphenyl-derivate, verfahren zu ihrer herstellung und ihre verwendung |